Sponsor Dossier
Otsuka Australia Pharmaceutical
Sponsor Dossier for Otsuka Australia Pharmaceutical. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
About
Otsuka Australia Pharmaceutical is an Australian Private Company with ABN 20601768754, registered in NSW. The entity is currently active and registered for GST.
Portfolio
Otsuka Australia Pharmaceutical has 5 brands on the ARTG, of which 5 are indexable and 5 carry a Product Information document. 2 brands are PBS-listed, 4 have a PBAC outcome on record, and 2 have an AusPAR on record. Notable brands include ABILIFY, BUSULFEX, JINARC, SAMSCA, ZIRDAWNY.
Therapeutic focus
— Renal: 2 brands — Psychiatry: 1 brand — Haematology: 1 brand — Rare Disease: 1 brand
PBS footprint
2 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-07-01, across 4 brands with a PBAC outcome on record. The latest AusPAR is 2026-08-19, across 2 brands with an AusPAR on record.